Conference Coverage
Conference Coverage
NAFLD patients with diabetes have higher fibrosis progression rate
Patients with type 2 diabetes had about a 2-year faster progression to fibrosis.
Conference Coverage
Triglyceride-lowering fails to show CV benefit in large fibrate trial
In the phase 3 PROMINENT trial, pemafibrate improved multiple lipid fractions in patients with type 2 diabetes, without any impact on...
Conference Coverage
Drug repurposing ‘fast track’ to new medicines for obesity, diabetes
“We would like to progress some of these compounds to preclinical and clinical trials, but need to raise the funds for this expensive research.”...
Conference Coverage
Tirzepatide’s benefits expand: Lean mass up, serum lipids down
New results from the SURMOUNT-1 trial of tirzepatide in people with obesity show further positive effects.
Conference Coverage
Dapagliflozin DELIVERs regardless of systolic pressure in HFpEF
The finding may alleviate long-standing concerns that starting modestly diuretic SGLT2 inhibitors in patients with heart failure might present a...
Conference Coverage
How to improve diagnosis of HFpEF, common in diabetes
Heart failure with preserved ejection fraction is common in people with type 2 diabetes but is often hard to recognize. Treatments newly proven to...
Conference Coverage
Once-weekly insulin promising in phase 3 trial in type 2 diabetes
Novo Nordisk’s insulin icodec was superior in lowering A1c compared with daily degludec without increasing the risk for moderate or severe...
Conference Coverage
Ezetimibe-statin combo lowers liver fat in open-label trial
A significant 5.8% decrease in hepatic steatosis was seen after 24 weeks’ treatment with ezetimibe and rosuvastatin comparing baseline with end of...
Conference Coverage
Cre8 EVO stent loses sweet spot in diabetes at 2 years: SUGAR
Outcomes once deemed “almost too good to be true” disappeared with longer follow-up in an all-comer population of patients with diabetes...
Conference Coverage
Emphasis on weight loss in new type 2 diabetes guidance
No major changes but several shifts in emphasis since the last update in 2019, including weight loss as a co–primary goal of management.